Viatris
At a glance
Viatris reported 2025 revenue of $14.25B, down 3% from $14.69B in 2024. Over 4 years since 2021 ($17.81B), that is a decline of about 5.4% a year. Operating margin was -18.7%, down from -0.2% in 2021. Revenue peaked in 2021 at $17.81B. The company posted a loss in 2021 and 2025.
In the last 12 months 2 insiders reported 1 open-market purchase ($5,202) and 2 sales ($1.1M). 1 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $810K by See Remarks Paul Campbell on Jun 26, 2026. Net, insiders were sellers of $1.1M.
Viatris filed 14 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), material agreement (3), officer or director change (3) and new financial obligation (2). The latest officer or director change was reported on May 4, 2026. It reported a material agreement or a completed acquisition or disposal 3 times.
1 of the 20 investors tracked here held Viatris at the last quarter end, worth $27M combined. It is the largest weight for Bridgewater Associates (0.1% of its portfolio). Added: Bridgewater Associates.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | - | - | - | - | - |
| Diluted EPS | $-1.05 | $1.71 | $0.05 | $-0.53 | $-3.00 |
| Dividend per share | $0.33 | $0.48 | $0.48 | $0.48 | $0.48 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined